Detalhe da pesquisa
1.
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.
Immunity
; 51(5): 885-898.e7, 2019 11 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31542340
2.
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Immunity
; 44(6): 1255-69, 2016 06 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27332730
3.
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity
; 45(4): 931-943, 2016 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-27717798
4.
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.
Nat Med
; 28(3): 545-556, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35228752
5.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36260981
6.
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Science
; 371(6529): 595-602, 2021 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33542131
7.
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science
; 374(6575): 1632-1640, 2021 Dec 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34941392
8.
Microbiome as an Immunological Modifier.
Methods Mol Biol
; 2055: 595-638, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31502171
9.
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.
Cell Res
; 29(10): 846-861, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31481761
10.
Anti-PD1 in the wonder-gut-land.
Cell Res
; 28(3): 263-264, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29336431
11.
[Gut microbiota and efficacy of cancer therapies]. / Rôle du microbiote intestinal dans la réponse aux thérapies anti-tumorales.
Biol Aujourdhui
; 211(1): 51-67, 2017.
Artigo
Francês
| MEDLINE | ID: mdl-28682227
12.
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota.
Oncoimmunology
; 6(1): e1132137, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28197360
13.
[The role of intestinal microbiota in the response to anti-tumor therapies]. / Microbiote intestinal et réponses aux thérapies anti-tumorales.
Med Sci (Paris)
; 32(11): 974-982, 2016 Nov.
Artigo
Francês
| MEDLINE | ID: mdl-28008838
14.
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Cancer Res
; 76(16): 4602-7, 2016 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27474734
15.
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
J Clin Invest
; 126(3): 921-37, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26854930
16.
Cancer and the gut microbiota: an unexpected link.
Sci Transl Med
; 7(271): 271ps1, 2015 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25609166
17.
Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
Cancer Res
; 75(20): 4292-301, 2015 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26359460
18.
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Cell Res
; 25(2): 208-24, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25582080
19.
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Science
; 350(6264): 1079-84, 2015 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-26541610
20.
Cell-death-associated molecular patterns as determinants of cancer immunogenicity.
Antioxid Redox Signal
; 20(7): 1098-116, 2014 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23394620